Monetary Management Group Inc Amgen Inc Transaction History

Monetary Management Group Inc

$383 Million
Q4 2024

A detailed history of Monetary Management Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Monetary Management Group Inc holds 14,021 shares of AMGN stock, worth $4.32 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

14,021

Previous 13,846 1.26%

Holding current value

$4.32 Million

Previous $4.46 Million 18.09%

% of portfolio

0.95%

Previous 1.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $45,286 - $57,454	175 Added 1.26%	14,021 $3.65 Million
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $123,752 - $134,952	-400 Reduced 2.81%	13,846 $4.46 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $91,962 - $111,758	-350 Reduced 2.4%	14,246 $4.45 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $83,349 - $100,613	310 Added 2.17%	14,596 $4.15 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $153,420 - $173,076	-600 Reduced 4.03%	14,286 $4.11 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $27,331 - $33,932	125 Added 0.85%	14,886 $4 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $400,684 - $473,801	-1,870 Reduced 11.24%	14,761 $3.28 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $5,644 - $6,880	-25 Reduced 0.15%	16,631 $4.02 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $40,080 - $50,926	175 Added 1.06%	16,656 $4.37 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 0.3%	16,481 $3.72 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $23,071 - $25,674	100 Added 0.61%	16,531 $4.02 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $89,900 - $99,453	-410 Reduced 2.43%	16,431 $3.97 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $259,538 - $297,018	-1,305 Reduced 7.19%	16,841 $3.79 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $504,141 - $590,662	2,375 Added 15.06%	18,146 $3.86 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $5,839 - $6,478	25 Added 0.16%	15,771 $3.84 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $22,191 - $25,860	100 Added 0.64%	15,746 $3.92 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $64,914 - $77,301	300 Added 1.95%	15,646 $3.6 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $181,384 - $201,714	-773 Reduced 4.8%	15,346 $3.9 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $262,098 - $321,630	-1,325 Reduced 7.6%	16,119 $3.8 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $150,348 - $199,402	825 Added 4.96%	17,444 $3.54 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $170,099 - $218,636	-899 Reduced 5.13%	16,619 $4.01 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $56,585 - $67,801	325 Added 1.89%	17,518 $3.39 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $503,722 - $567,805	-2,785 Reduced 13.94%	17,193 $3.27 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $522,712 - $610,172	-2,930 Reduced 12.79%	19,978 $3.89 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $27,793 - $31,333	-150 Reduced 0.65%	22,908 $4.75 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $59,778 - $67,143	-360 Reduced 1.54%	23,058 $4.26 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $162,652 - $190,080	-960 Reduced 3.94%	23,418 $3.99 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $77,643 - $86,751	460 Added 1.92%	24,378 $4.24 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $166,453 - $190,045	995 Added 4.34%	23,918 $4.46 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,923	22,923 $3.95 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.

Account

Monetary Management Group Inc Amgen Inc Transaction History